Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Chiara Corti, M.D.

Concepts (123)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunoconjugates720239681.920 Why?
Breast Neoplasms212024211561.550 Why?
Thymus Neoplasms420222781.160 Why?
Thymoma320221911.080 Why?
Neoadjuvant Therapy3202428960.860 Why?
Neoplasms142024223860.810 Why?
Breast Neoplasms, Male220202120.770 Why?
Artificial Intelligence3202326590.660 Why?
DNA Mismatch Repair220204330.660 Why?
Antineoplastic Agents62023137080.620 Why?
Cancer Vaccines2202110440.560 Why?
Gastrointestinal Stromal Tumors120226170.530 Why?
Immunotherapy8202447280.530 Why?
Microsatellite Instability120197260.500 Why?
Tumor Microenvironment3202239390.400 Why?
Receptor, erbB-26202425860.340 Why?
Antineoplastic Combined Chemotherapy Protocols72024118430.330 Why?
Neoplasms, Glandular and Epithelial220224890.290 Why?
Receptors, Estrogen3202422430.280 Why?
Brain Neoplasms3202391820.270 Why?
Melanoma2202257400.270 Why?
Humans4820247684510.240 Why?
PTEN Phosphohydrolase2202011190.230 Why?
Molecular Targeted Therapy3202428340.210 Why?
Compassionate Use Trials12022500.200 Why?
Ifosfamide120232340.200 Why?
Polymyositis12022770.200 Why?
Chemotherapy, Adjuvant2202135500.200 Why?
Mutation32022302430.190 Why?
Female2420243969430.180 Why?
Vaccines, Virus-Like Particle12021430.180 Why?
Vaccines, Subunit120211590.180 Why?
Vaccines, Inactivated120211850.170 Why?
Triazines120223120.170 Why?
Prognosis62024300280.170 Why?
Vaccines, Attenuated120213150.170 Why?
Oxazoles120211990.170 Why?
Antibodies, Viral2202132120.170 Why?
Apocrine Glands12019320.170 Why?
Pyrroles2202211270.160 Why?
Proto-Oncogene Proteins c-kit120227270.150 Why?
Vaccines, Synthetic120216220.150 Why?
Estrogens1202415310.150 Why?
Lung Neoplasms42023135890.140 Why?
Carcinoma, Lobular120214800.140 Why?
Genetic Counseling120206330.140 Why?
Aromatase Inhibitors120205180.130 Why?
Exons1202223920.130 Why?
Tamoxifen120209680.130 Why?
Gonadotropin-Releasing Hormone1202011490.120 Why?
Quinazolines1202113760.120 Why?
Carcinoma, Intraductal, Noninfiltrating120219340.120 Why?
Carcinoma, Ductal, Breast1202110920.110 Why?
Antigens, Neoplasm1202220030.110 Why?
Drug Approval120218170.110 Why?
Membrane Transport Proteins1201910360.110 Why?
Carcinoma, Non-Small-Cell Lung2202354260.110 Why?
Neoplasm Staging22024112490.100 Why?
Antineoplastic Agents, Hormonal1202015360.100 Why?
Radiosurgery1202113540.100 Why?
Immunotherapy, Adoptive1202215050.100 Why?
High-Throughput Screening Assays120179400.100 Why?
Pyrazoles1202220240.100 Why?
Prospective Studies52023549140.100 Why?
Proto-Oncogene Proteins B-raf1202120720.090 Why?
Combined Modality Therapy1202185590.080 Why?
Autoimmune Diseases1202222600.080 Why?
Vaccination1202134340.080 Why?
Pyridines1202128880.080 Why?
Randomized Controlled Trials as Topic52024103580.080 Why?
Protein Kinase Inhibitors2202357090.080 Why?
Genetic Testing1202035860.070 Why?
Epithelial Cells1201936970.070 Why?
Neoplasm Proteins1201936110.070 Why?
Clinical Trials as Topic1202180510.060 Why?
Immunohistochemistry12019111380.060 Why?
Reproducibility of Results12022202310.060 Why?
Gene Expression Regulation, Neoplastic1202086350.060 Why?
Incidence12021215520.050 Why?
Mesna12023620.050 Why?
Treatment Outcome42022654090.050 Why?
Early Detection of Cancer1201732300.050 Why?
Immunologic Factors2202216000.050 Why?
Algorithms12022141580.050 Why?
Bystander Effect12022900.050 Why?
Signal Transduction12024236380.050 Why?
Platinum120222220.050 Why?
Technology120212960.040 Why?
Workflow120238610.040 Why?
Disease-Free Survival2202068560.040 Why?
Receptors, Progesterone1202311450.040 Why?
Retrospective Studies32022818340.040 Why?
Patient Care120236290.040 Why?
Cardiovascular Diseases12023156380.040 Why?
Quality of Life32023134970.030 Why?
Clinical Trials, Phase III as Topic120218760.030 Why?
Hyperplasia1201911540.030 Why?
Axilla120186290.030 Why?
Neoplasm Recurrence, Local2202394250.030 Why?
Indoles1202218340.030 Why?
MAP Kinase Signaling System1202114890.030 Why?
Gene Amplification1201710910.030 Why?
Breast1202119760.030 Why?
Animals220211694180.030 Why?
Angiogenesis Inhibitors1202220620.030 Why?
Lymph Node Excision1201812760.030 Why?
In Situ Hybridization, Fluorescence1201725250.020 Why?
HeLa Cells1201730900.020 Why?
Recurrence1202385100.020 Why?
Medical Oncology1202323470.020 Why?
Neoplasm Invasiveness1201836370.020 Why?
Male320213647810.020 Why?
Follow-Up Studies22019394300.020 Why?
Lymph Nodes1201834720.020 Why?
Case-Control Studies12023222930.020 Why?
Survival Rate12020128750.020 Why?
Aged, 80 and over22020596800.010 Why?
Aged320201715200.010 Why?
Skin Neoplasms1202158910.010 Why?
Middle Aged320202234180.010 Why?
Adult320202235420.010 Why?
Brain12023274380.010 Why?
Adolescent12022891680.010 Why?
Corti's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (123)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.